Shanghai Hile Bio-tech (603718) — Capital Reinvestment Ratio
Shanghai Hile Bio-tech (603718) has a Capital Reinvestment Ratio of 0.06x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥43.72 Million) in capital expenditures (CN¥2.64 Million). Check 603718 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Hile Bio-tech Capital Reinvestment Ratio (2011–2025)
This chart tracks Shanghai Hile Bio-tech's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see Shanghai Hile Bio-tech operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Shanghai Hile Bio-tech (2011–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Hile Bio-tech from 2011 to 2025. See 603718 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | CN¥58.83 Million | CN¥12.17 Million | ▲ +14.6% |
| 2024 | 0.18x | CN¥46.47 Million | CN¥8.39 Million | ▲ +166.5% |
| 2022 | 0.07x | CN¥292.91 Million | CN¥19.85 Million | ▼ -92.2% |
| 2021 | 0.87x | CN¥43.63 Million | CN¥37.78 Million | ▲ +325.5% |
| 2020 | 0.20x | CN¥167.68 Million | CN¥34.12 Million | ▼ -69.1% |
| 2019 | 0.66x | CN¥59.25 Million | CN¥39.03 Million | ▼ -88.9% |
| 2018 | 5.94x | CN¥18.92 Million | CN¥112.29 Million | ▲ +140.9% |
| 2017 | 2.46x | CN¥34.92 Million | CN¥86.04 Million | ▲ +96.1% |
| 2016 | 1.26x | CN¥108.39 Million | CN¥136.16 Million | ▲ +82.0% |
| 2015 | 0.69x | CN¥201.69 Million | CN¥139.18 Million | ▼ -12.6% |
| 2014 | 0.79x | CN¥110.22 Million | CN¥87.07 Million | ▲ +369.2% |
| 2013 | 0.17x | CN¥147.63 Million | CN¥24.86 Million | ▼ -40.4% |
| 2012 | 0.28x | CN¥122.48 Million | CN¥34.58 Million | ▼ -18.2% |
| 2011 | 0.35x | CN¥149.61 Million | CN¥51.64 Million | — |